Drug information for METVIXIA
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
CREAM; TOPICAL
EQ 16.8% BASE
Prescription
(Reference Drug)
METHYL AMINOLEVULINATE HYDROCHLORIDE
methyl 5-aminolevulinate
GALDERMA LABS LP
21415
2008-06-30 Letter
2008-06-30 Label
2006-03-21 Review
2005-06-07 Letter
2005-06-07 Label
2004-07-30 Letter
2004-07-30 Label
Drug Adverse Effects information for METVIXIA
Role code
Indications
Reaction
# Reports
PS
ACTINIC KERATOSIS
APPLICATION SITE VESICLES
1
PS
ACTINIC KERATOSIS
DRUG HYPERSENSITIVITY
1
PS
ACTINIC KERATOSIS
SKIN TEST POSITIVE
1
PS
BASAL CELL CARCINOMA
APPLICATION SITE VESICLES
1
PS
BASAL CELL CARCINOMA
DRUG HYPERSENSITIVITY
1
PS
BASAL CELL CARCINOMA
SKIN TEST POSITIVE
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
ATYPICAL FIBROXANTHOMA
1
Ads by Google